This suggest us that a compensatory mechanism may overcome the blockade of TNFα and IL1β secreted by CAR-T and PBMC, thus promoting HUVEC activation and possible CRS/ICANS events in vivo. This evidence concerns the gene IL1B and congenital rubella syndrome.